glp 1 agonist exenatide Treatment with GLP-1 Receptor Agonists Gut hormone-based pharmacology: novel formulations

Liver Int 31(9):13151324

References: [1] pmc/articles/PMC6271067/ [2] science/article/abs/pii/S00219673 12014550 [3] United States TB500 & BPC-157 Blend Nasal Spray Specifications: BPC-157: Sequence : Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ma Asp-Asp Ala Gly Leu Val Molecular Formula: C62H98N16O22 Molecular Weight: 1419.556 Explore our complete range of BPC-157 products here

Understanding how these drugs work provides essential context for their elimination from the body

Route of Administration How a peptide is delivered dramatically affects how long it stays in the body: Subcutaneous injection : slower absorption, longer duration Intramuscular injection : faster peak concentration, moderate duration Oral and intranasal peptides : often rapidly broken down, requiring protective technologies or higher doses For example, oral BPC-157 may work primarily through gut-localized pathways, while injectable versions may provide broader systemic benefits